UPL

UPL (₹534.90) exhibits a short-term bounce within a broader downtrend. On the daily chart, price sits above the 20-period EMA and SMA, with a bullish Supertrend signal, suggesting immediate buying pressure. This is corroborated by a high-severity upward volume anomaly on November 6 (+1.6%) and moderate participation on November 2. However, trend strength is weak (ADX 16.8), and price remains below key longer-term averages (50-day and 200-day SMAs). The monthly and weekly trends remain bearish, with price below all major moving averages and Supertrends. UPL is trading near the upper end of its 20-day range (+78.2%) but still significantly off its 52-week highs (-33.6% drawdown). Immediate resistance lies at ₹542.43 (1.41% above), while support is tight at ₹534.47 (0.08% below). A sustained move above ₹542.43 would be required to confirm a reversal of the short-term momentum; failure to hold above recent lows may see price retest deeper supports.

UPL reported its Q2 FY27 results on November 2, 2026, revealing a divergence between top-line pressure and margin resilience. Consolidated net profit declined 24–26% year-on-year to ₹421–452 crore, driven by lower sales that reduced total income by 1.32%. However, EBITDA rose 5%, supported by improved operating margins and favorable foreign exchange movements that offset weaker global crop protection volumes. The company highlighted growth in its Specialty Chemicals and Seeds segments and announced an $110 million acquisition of Egypt-based Misr Hytech Seed International via its subsidiary Advanta.

Market sentiment reflected these mixed signals. On November 5, Bajaj Broking identified UPL as a potential candidate for short-covering activity due to elevated open interest and weak price action. Separately, Motilal Oswal assigned a neutral rating with a target price of ₹580 on November 3, citing the current outlook on the agrochemical company's performance.

UPL Limited (NSE: UPL) has updated its investor communications following the release of unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2026. On November 2, 2026, the company held an earnings conference call and an Analyst/Investor Meet, with transcripts subsequently filed with the NSE on November 6, 2026. These filings provide the detailed management commentary underlying the reported financial performance.

Market pricing reflects a shift in valuation as of the observation date of November 6, 2026. The stock closed at ₹534.9, up from the previous recorded price of ₹526.5. This movement coincides with the availability of the post-earnings discussion transcripts, which allow investors to assess management's outlook and operational updates beyond the headline numbers.

UPL Limited reported unaudited financial results for Q2 and H1 FY2027 (ended September 30, 2026), alongside significant governance and strategic updates. Consolidated revenue for the quarter was ₹11,860 crore, down 1% year-over-year, while EBITDA rose 5% to ₹2,312 crore with a margin expansion of 120 basis points to 19.5%. For the half-year, revenue grew 4% to ₹22,041 crore, and operational PATMI increased 33% to ₹441 crore. The company announced Advanta’s agreement to acquire 99.98% of Egypt’s Misr Hytech Seed International for approximately $110 million, pending regulatory approvals by January 31, 2027. Additionally, UPL refinanced $400 million of a term loan due in December 2026 to FY2032. Governance changes include the appointment of Mr. Shatmanyu Shrivastava as a Non-Executive Director and S R B C & CO LLP as statutory auditors for five years from 2027. A composite arrangement remains subject to further approvals and is not reflected in these results.

UPL’s Q2 FY2026-27 (Sep 2026) marks a decisive return to profitability, with Net Profit surging to ₹452 crore from a ₹73 crore loss in Q1. Operating Profit expanded sequentially to ₹2,068 crore, driven by higher Sales of ₹11,860 crore, though YoY sales growth turned negative at -1%. Earnings quality remains robust, evidenced by CFO/EBITDA of 93% for the year ended Mar 2026 and a significant reduction in Interest costs to ₹3,281 crore (TTM). The balance sheet shows deleveraging progress: Borrowings fell to ₹23,576 crore by Mar 2026 before rising to ₹34,240 crore in Sep 2026, while Non-current Liabilities dropped sharply to ₹14,559 crore. ROCE improved to 10% in Mar 2026, but Working Capital Days compressed to just 5 days, suggesting aggressive working capital management or potential inventory buildup risks given Inventory Days rose to 179 days. Foreign Institutional Investors increased their stake to 42.36%, signaling renewed confidence.

UPL faces a challenging operational and market environment, marked by significant profitability declines and technical weakness. For Q2 FY27, consolidated net profit fell 26.14% year-on-year to ₹452 crore, driven by a 1.32% reduction in total income despite growth in specialty chemicals and seeds. Another reporting instance cites a 24% YoY profit drop to ₹421 crore with rising EBITDA, highlighting volatility in earnings quality. The stock has underperformed broadly, recording a -33.6% year-to-date return and a -27.1% one-year return, with a current drawdown of -33.6% against a maximum drawdown of -40.3%. Technical indicators show mixed signals: while the daily supertrend is bullish, the weekly and monthly trends are bearish, with the minus DI exceeding the plus DI on both timeframes. A Motilal Oswal rating of 'Neutral' with a target of ₹580 suggests limited upside from the recent close of ₹534.9.